Oruka Therapeutics, Inc. ($ORKA)
Filing Information
| Accession Number | 0000907654-26-000077 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 14, 2026 |
| Document | View SEC Filing |
Transactions
10
Total Shares
156,000
Total Value
$6,244,408.94
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
General Counsel | Common Stock | โ | Aug 14, 2026 | Exercise/Conversion | 10,000 | $7.80 | $78,000.00 | 41,034 | Direct | โ | View Details | |
General Counsel | Common Stock | โ | Aug 14, 2026 | Exercise/Conversion | 42,000 | $12.50 | $525,000.00 | 83,034 | Direct | โ | View Details | |
General Counsel | Common Stock | โ | Aug 14, 2026 | Sale | 3,630 | $106.05 | $384,962.95 | 79,404 | Direct | โ | View Details | |
General Counsel | Common Stock | โ | Aug 14, 2026 | Sale | 10,434 | $107.14 | $1,117,900.85 | 68,970 | Direct | โ | View Details | |
General Counsel | Common Stock | โ | Aug 14, 2026 | Sale | 14,696 | $107.97 | $1,586,778.56 | 54,274 | Direct | โ | View Details | |
General Counsel | Common Stock | โ | Aug 14, 2026 | Sale | 10,200 | $109.11 | $1,112,953.62 | 44,074 | Direct | โ | View Details | |
General Counsel | Common Stock | โ | Aug 14, 2026 | Sale | 9,193 | $110.00 | $1,011,265.85 | 34,881 | Direct | โ | View Details | |
General Counsel | Common Stock | โ | Aug 14, 2026 | Sale | 3,847 | $111.14 | $427,547.12 | 31,034 | Direct | โ | View Details | |
General Counsel | Employee Warrant (right to buy) | Derivative | Aug 14, 2026 | Exercise/Conversion | 10,000 | $0.00 | $0.00 | 89,996 | Direct | โ | View Details | |
General Counsel | Employee Stock Option (right to buy) | Derivative | Aug 14, 2026 | Exercise/Conversion | 42,000 | $0.00 | $0.00 | 120,500 | Direct | โ | View Details |